Theodore Grabow, MD
Pain Medicine · Towson, MDNPI 1083647259
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $841 and has fallen 84.8% since, to $128 in 2025.
Across 93 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$356
- Boston Scientific$157
- Vertos Medical, Inc.$143
- Amgen$140
- Saluda Medical Americas, Inc.$106
- Scilex Pharmaceuticals Inc.$103
- plus $869 from 19 others
What the payments were for
- Food & beverage$1,873100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 16 | $356 |
| Boston Scientific | 8 | $157 |
| Vertos Medical, Inc. | 5 | $143 |
| Amgen | 12 | $140 |
| Saluda Medical Americas, Inc. | 2 | $106 |
| Scilex Pharmaceuticals Inc. | 6 | $103 |
| Averitas Pharma Inc. | 4 | $101 |
| MDD US Operations, LLC | 4 | $100 |
| Daiichi Sankyo Inc. | 6 | $97 |
| Teva Pharmaceuticals USA, Inc. | 3 | $67 |
| Lilly USA, LLC | 4 | $61 |
| Abbott | 3 | $61 |
| Fidia Pharma USA Inc. | 2 | $60 |
| Nevro Corp. | 3 | $52 |
| Upsher-smith Laboratories LLC | 2 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Pacira Therapeutics, Inc. | 2 | $31 |
| Electronic Waveform Lab, Inc. | 2 | $29 |
| Novartis | 1 | $21 |
| MML US, Inc. | 1 | $21 |
| AbbVie | 1 | $18 |
| Kaleo, Inc. | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Shionogi Inc | 1 | $15 |
| International Rehabilitative Sciences, Inc | 1 | $15 |
How this compares
$1,873 in reported general payments places this provider in the 55th percentile of 144 pain medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 137 | $2,292 |
| Duloxetine Hcl | 15 | $368 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Towson
- Ayodeji OmosuleTowson$10K
- Vipul MangalOxon Hill$764K
- Randy DavisBaltimore$169K
- Paul ChristoBaltimore$137K
- Kunal SoodGermantown$70K
- Ali TurabiBethesda$47K
- Behnam JafarpourBaltimore$45K
- Eric FinkelsteinOwings Mills$37K
- Ankush JainBethesda$26K
- Sudhir RaoMount Airy$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.